FORENSIC TOXICOLOGY - Bio Medical Forensics

Jufer, Rebecca A. PhD*, Barry S. Levine, PhD, Deborah
Green Johnson, BS, Mary Ripple, MD, and David R.
Fowler, MD, State of Maryland, Office of the Chief
Medical Examiner, 111 Penn Street, Baltimore, MD 21201
Juhascik, Matthew P. BS, MS*, Adam Negrusz, PhD, and
Robert E. Gaensslen, PhD, Department of Pharmaceutics
and Pharmacodynamics, College of Pharmacy, University
of Illinois at Chicago, Chicago, IL 60612; Christine
Moore, PhD, U.S. Drug Testing Laboratories, Inc., 1700
South Mount Prospect Road, Des Plaines, IL 60018; Paul
J. Goldstein and Paul S. Levy, Epidemiology and
Biostatistics, School of Public Health, University of Illinois
at Chicago, Chicago, IL 60612; Pam Greene, Palomar
Pomerado Medical Center, 555 West Valley Parkway,
Escondido, CA 92025; Alice Linder, Scott & White
Memorial Hospital, 2401 South 31st Street, Temple , TX
76508; Diana Faugno, BSN, RN, Palomar Pomerado
Medical Center, 555 West Valley Parkway, Escondido, CA
92025; Linda Ledray, Hennepin County Medical Center,
701 Park Avenue, Minneapolis, MN 55415; Barbara
Haner, Providence Everett Medical Center, 1321 Colby
Avenue, Everett, WA 98206
Kacinko, Sherri L. BS*, National Institute on Drug Abuse,
5500 Nathan Shock Drive, Baltimore, MD 21224 ;
Hendree E. Jones, PhD, Johns Hopkins University, Johns
Hopkins Bayview Medical Center, 4940 Eastern Avenue
D-3-E, Baltimore, MD 21224; Rolley E. Johnson,
PharmD, Reckitt Benckiser Pharmaceuticals, 10710
Midlothian Turnpike Suite 430, Richmond, VA 23235;
Robin E. Choo, PhD, University of Pittsburgh - Titusville,
504 East Main Street, BCS 127, Titusville, PA; and Diaa
M. Shakleya, PhD, and Marilyn A. Huestis, PhD,
Chemistry & Drug Metabolism, Intramural Research,
National Institute on Drug Abuse, National Institutes of
Health, 5500 Nathan Shock Drive, Baltimore, MD 21224
Kacinko, Sherri L. PhD*, Allan Xu, PhD, Matthew M.
McMullin, MS, and Barry K. Logan, PhD, NMS Labs,
3701 Welsh Road, Willow Grove, PA 19090
Kacinko, Sherri L. PhD*, and Barry K. Logan, PhD, NMS
Labs, 3701 Welsh Road, Willow Grove, PA 19090
Kalasinsky, Kathryn S. PhD, Division of Forensic
Toxicology, Armed Forces Institute of Pathology,
Washington, DC 20306; John Hugel, BSc, Drug Analysis
Service, Health Canada, Toronto, Ontario M1P 4R7,
Canada; Stephen J. Kish, PhD*, Centre for Addiction and
Mental Health, Human Neurochemical Pathology Lab,
Toronto, Ontario M5T 1R8, Canada
Karas, Roman BS*, FBI Laboratory, 2501 Investigation
Parkway, Chemistry Unit, Quantico, VA 22135-0001
Karas, Roman BS*, FBI Laboratory, 2501 Investigation
Parkway, Chemistry Unit, Quantico, VA 22135-0001
Index 83
Absence of Elevated Carboxyhemoglobin
Following Inhalation of Automobile Exhaust
Estimate of the Incidence of Drug-Facilitated
Sexual Assault in the United States
Disposition of Buprenorphine and
Norbuprenorphine in Human Meconium
Identification of Markers of JWH-018 and
JWH-073 Use in Human Urine
Propofol Analytical Challenges and
Interpretation
Use of MDA (the “Love Drug”) and
Methamphetamine in Toronto by
Unsuspecting Users of Ecstasy (MDMA)
Detection of Fentanyl and Lidocaine in Dried
Blood Spots Using High Performance Liquid
Chromatography Tandem Mass Spectrometry
Validation of a High Performance Liquid
Chromatography Tandem Mass Spectrometry
Method for the Detection of Opioids in Hair
175
226
112
15
50
221
51
53